Serviços Personalizados
Journal
artigo
Indicadores
Compartilhar
SMAD. Revista eletrônica saúde mental álcool e drogas
versão On-line ISSN 1806-6976
Resumo
DA-SILVA, Thiago Guimarães; VASCONCELOS, Pedro Fonseca de e MOURA, Ivan Gilson Silva. A current approach to the use of antidepressants in the management of postpartum depression. SMAD, Rev. Eletrônica Saúde Mental Álcool Drog. (Ed. port.) [online]. 2021, vol.17, n.1, pp.101-108. ISSN 1806-6976. https://doi.org/10.11606/issn.1806-6976.smad.2021.159781.
OBJECTIVE: this study aimed to characterize the use of antidepressants in the management of postpartum depression. METHOD: an integrative literature review of the PubMed and Virtual Health Library databases was used, with the application of descriptors, aiming to answer the guiding question of the work, between February 25th and March 10th, 2019. Based on the inclusion and exclusion criteria, 23 articles were selected that were later submitted to categorization. RESULTS: sertraline should be the drug of choice for the pharmacological treatment of puerperal depression. It was also found that the prophylactic use of antidepressants in susceptible women is controversial and little is known about the possible side effects. In addition, it was found that there is no consensus on the superiority of pharmacological therapy to the detriment of psychotherapies. CONCLUSION: there is evidence supporting the use of sertraline, paroxetine, duloxetine, nortriptyline and imipramine to treat women with postpartum depression, and breastfeeding is always recommended. It is worth noting that the need for studies with representative samples to validate or restrict the use of psychotropic drugs in the prophylaxis of puerperal depression emerges.
Palavras-chave : Postpartum Depression; Psychotropics; Antidepressant Agents; Sertraline.